Mabpharm Statements
21
Mabpharm Income Statement
B
M
CNY (except Earnings per share)
Financial
Revenue
Cost of sales
Gross profit
Research and development
Selling, general and administrative
Total operating expenses
Operating income
Interest expense
Other income
Income before tax
Provision for income taxes
Net income
Diluted earnings per share
Shares outstanding after dilution
108.48
100
14.127
13
94.356
87
56.293
51.9
131.01
120.8
186.62
172
-92.266
-85.05
-5.303
-4.9
—
0
-97.569
-89.9
—
0
-97.569
-89.9
-0.024
4 124.08
43.141
100
5.725
13.3
37.416
86.7
63.684
147.6
79.173
183.5
143.49
332.6
-106.07
-245.9
-3.286
-7.6
—
0
-109.36
-253.5
—
0
-109.36
-253.5
-0.027
4 124.08
44.02
6.198
37.822
59.527
74.838
130.65
-92.833
-7.166
—
-99.999
—
-99.999
-0.024
4 124.08
27.071
100
4.321
16
22.75
84
69.916
258.3
55.792
206.1
111.96
413.6
-89.21
-329.5
-5.04
-18.6
—
0
-94.01
-347.3
—
0
-94.01
-347.3
-0.023
4 124.08
28.847
100
11.054
38.3
17.793
61.7
77.99
270.4
63.096
218.7
128.88
446.8
-111.09
-385.09
-5.722
-19.8
—
0
-116.81
-404.9
—
0
-116.81
-404.9
-0.028
4 124.08
1.636
100
0.008
0.5
1.628
99.5
100.12
6119.6
56.3
3441.3
146.04
8926.7
-144.41
-8827.2
-2.17
-132.6
—
0
-146.58
-8959.8
—
0
-146.58
-8959.8
-0.036
4 124.08
81.246
100
16.769
20.6
64.477
79.4
163.46
201.2
43.755
53.9
204.77
252
-140.29
-172.7
-4.87
-6
—
0
-145.16
-178.7
—
0
-145.16
-178.7
-0.035
4 124.08
—
100
—
0
—
0
59.59
0
35.054
0
84.832
0
-84.832
0
-45.612
0
—
0
-130.44
0
—
0
-130.44
0
-0.032
4 124.08
—
100
—
0
—
0
60.828
0
30.741
0
73.414
0
-73.414
0
19.226
0
—
0
-54.188
0
—
0
-54.188
0
-0.013
4 124.08
—
100
—
0
—
0
75.486
0
35.07
0
104.15
0
-104.15
0
17.3
0
—
0
-86.848
0
—
0
-86.848
0
-0.021
4 129.42
—
100
—
0
—
0
58.703
0
27.882
0
83.046
0
-83.046
0
-5.108
0
—
0
-115.68
0
—
0
-115.68
0
-0.033
3 474.7
—
100
—
0
—
0
62.661
0
29.426
0
85.333
0
-85.333
0
-3.31
0
—
0
-109.49
0
-2.834
0
-106.65
0
-0.036
2 974.05
—
100
—
0
—
0
26.322
0
12.702
0
34.358
0
-34.358
0
-3.466
0
—
0
-43.106
0
—
0
-43.106
0
-0.03
1 450.1